PrEp Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F23%3A10452347" target="_blank" >RIV/00669806:_____/23:10452347 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11140/23:10452347
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=yJg3qH9F8Q" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=yJg3qH9F8Q</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/vaccines11010122" target="_blank" >10.3390/vaccines11010122</a>

Result language
angličtina
Original language name
PrEp Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future
Original language description
With no expected vaccine for HIV in the near future, we aimed to define the currentsituation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central andEastern Europe (CEE). The Euroguidelines CEE Network Group members were invited to respondto a 27-item survey including questions on PrEP (response rate 91.6%). PrEP was licensed in 68.2%;95 centers offered PrEP and the estimated number on PrEP was around 9000. It was available in daily(40.1%), on-demand (13.3%), or both forms (33.3%). The access rate was <1-80%. Three major barriersfor access were lack of knowledge/awareness among people who are in need (59.1%), not beingreimbursed (50.0%), and low perception of HIV risk (45.5%). Non-occupational PEP was available in86.4% and was recommended in the guidelines in 54.5%. It was fully reimbursed in 36.4%, only foraccidental exposures in 40.9%, and was not reimbursed in 22.72%. Occupational PEP was availablein 95.5% and was reimbursed fully. Although PrEP scale-up in the region has gained momentum, ahuge gap exists between those who are in need of and those who can access PrEP. Prompt action isrequired to address the urgent need for PrEP scale-up in the CEE region.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30303 - Infectious Diseases

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)